Fetal concentrations of the growth factors TGF-α and TGF-β1 in relation to normal and restricted fetal growth at term

Cytokine

Volumn 60, Issue 1, 2012, Pages 157-161

  Briana, Despina D ^a   Liosi, Sofia ^a   Gourgiotis, Dimitrios ^a   Boutsikou, Maria ^a   Marmarinos, Antonios ^a   Baka, Stavroula ^a   Hassiakos, Dimitrios ^a   Malamitsi Puchner, Ariadne ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Fetus; Intrauterine growth restriction; TGF ; TGF 1; Umbilical cord blood

Indexed keywords

TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; ARTICLE; BIRTH WEIGHT; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FETUS; FETUS BLOOD; GENDER; GESTATIONAL AGE; HUMAN; INFLAMMATION; INTRAUTERINE GROWTH RETARDATION; MATERNAL AGE; NEWBORN; PARITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SHEAR STRESS; UMBILICAL CORD BLOOD; VAGINAL DELIVERY;

ADULT; BIRTH WEIGHT; DELIVERY, OBSTETRIC; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FETAL BLOOD; FETAL GROWTH RETARDATION; FETUS; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE; MALE; MATERNAL AGE; MULTIVARIATE ANALYSIS; PREGNANCY; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84865434523     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2012.06.005     Document Type: Article

References (49)

1. Brodsky D., Christou H. Current concepts in intrauterine growth restriction. J Intensive Care Med 2004, 19:307-319.
2. Khong T.Y., De Wolf F., Robertson W.B., Brosens I. Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants. British J Obstet Gynaec 1986, 93:1049-1059.
3. Scifres C.M., Nelson D.M. Intrauterine growth restriction, human placental development and trophoblast cell death. J Physiol 2009, 587(Pt 14):3453-3458.
4. Crocker I.P., Cooper S., Ong S.C., Baker P.N. Differences in apoptotic susceptibility of cytotrophoblasts and syncytiotrophoblasts in normal pregnancy to those complicated with preeclampsia and intrauterine growth restriction. Am J Pathol 2003, 162:637-643.
5. Pardi G., Cetin I. Human fetal growth and organ development: 50 years of discoveries. Am J Obstet Gynecol 2006, 194:1088-1099.
6. Laskowska M., Laskowska K., Leszczynska-Gorzelak B., Oleszczuk J. Comparative analysis of the maternal and umbilical interleukin-8 levels in normal pregnancies and in pregnancies complicated by preeclampsia with intrauterine normal growth and intrauterine growth retardation. J Matern Fetal Neonatal Med 2007, 20:527-532.
7. Amarilyo G., Oren A., Mimouni F.B., Ochshorn Y., Deutsch V., Mandel D. Increased cord serum inflammatory markers in small-for-gestational-age neonates. J Perinatol 2011, 31:30-32.
8. Holcberg G., Huleihel M., Sapir O., Katz M., Tsadkin M., Furman B., et al. Increased production of tumor necrosis factor-alpha TNF-alpha by IUGR human placentae. Eur J Obstet Gynecol Reprod Biol 2001, 94:69-72.
9. Marzioni D., Capparuccia L., Todros T., Giovannelli A., Castellucci M. Growth factors and their receptors: fundamental molecules for human placental development. Ital J Anat Embryol 2005, 110:183-187.
10. Lysiak J.J., Han V.K., Lala P.K. Localization of transforming growth factor alpha in the human placenta and decidua: role in trophoblast growth. Biol Reprod 1993, 49:885-894.
11. Karmakar S., Das C. Regulation of trophoblast invasion by IL-1beta and TGF-beta1. Am J Reprod Immunol 2002, 48:210-219.
12. Marquardt H., Hunkapiller M.W., Hood L.E., Todaro G.J. Rat transforming growth factor type 1: structure and relation to epidermal growth factor. Science 1984, 223:1079-1082.
13. Bissonnette F., Cook C., Geoghegan T., Steffen M., Henry J., Yussman M.A., et al. Transforming growth factor-alpha and epidermal growth factor messenger ribonucleic acid and protein levels in human placentas from early, mid, and late gestation. Am J Obstet Gynecol 1992, 166:192-199.
14. Carver J.D., Barness L.A. Trophic factors for the gastrointestinal tract. Clin Perinatol 1996, 23:265-285.
15. Schilling B., Yeh J. Transforming growth factor-beta(1), -beta(2), -beta(3) and their type I and II receptors in human term placenta. Gynecol Obstet Invest 2000, 50:19-23.
16. Lea R.G., Riley S.C., Antipatis C., Hannah L., Ashwoth C.J., Clark D.A., et al. Cytokines and the regulation of apoptosis in reproductive tissues: a review. Am J Reprod Immunol 1999, 42:100-109.
17. Derynck R. The physiology of transforming growth factor-alpha. Adv Cancer Res 1992, 58:27-52.
18. Fortunato S.J., Menon R., Lonbardi S.J. Interleukin-10 and transforming growth factor-beta inhibit amniochorion tumor necrosis factor-alpha production by contrasting mechanisms of action: therapeutic implications in prematurity. Am J Obstet Gynecol 1997, 177:803-809.
19. Gardosi J., Chang A., Kaylan B., Sahota D., Symonds E.M. Customised antenatal growth charts. Lancet 1992, 339:283-287.
20. Baschat A.A., Galan H.L., Bhide A., Berg C., Kush M.L., Oepkes D. Doppler and biophysical assessment in growth restricted fetuses: distribution of test results. Ultrasound Obstet Gynecol 2006, 27:41-47.
21. Acharya G., Wilsgaard T., Berntsen G.K., Maltau J.M., Kiserud T. Reference ranges for serial measurements of umbilical artery Doppler indices in the second half of pregnancy. Am J Obstet Gynecol 2005, 192:937-944.
22. Ott W.J. Diagnosis of intrauterine growth restriction: comparison of ultrasound parameters. Am J Perinatol 2002, 19:133-137.
23. Baschat A.A. Doppler application in the delivery timing of the preterm growth-restricted fetus: another step in the right direction. Ultrasound Obstet Gynecol 2004, 23:111-118.
24. Karsdorp V.H., van Vugt J.M., van Geijn H.P., Kostense P.J., Arduini D., Montenegro N., et al. Clinical significance of absent or reversed end diastolic velocity waveforms in umbilical artery. Lancet 1994, 344:1664-1668.
25. Burkhardt T., Schaffer L., Schneider C., Zimmermann R., Kurmanavicious J. Reference values for the weight of freshly delivered term placentas and for placental weight-birth weight ratios. Eur J Obstet Gynecol Reprod Biol 2006, 128:248-252.
26. Jansson T., Powell T.L. Role of the placenta in fetal programming: underlying mechanisms and potential interventional approaches. Clin Sci (Lond) 2007, 113:1-13.
27. Macara L., Kingdom J.C., Kaufmann P., Kohnen G., Hair J., More I.A., et al. Structural analysis of placental terminal villi from growth-restricted pregnancies with abnormal umbilical artery Doppler waveforms. Placenta 1996, 17:37-48.
28. Jain K., Kavi V., Raghuveer C.V., Sinha R. Placental pathology in pregnancy-induced hypertension (PIH) with or without intrauterine growth retardation. Indian J Pathol Microbiol 2007, 50:533-537.
29. Schreiber A.B., Winkler M.E., Derynck R. Transforming growth factor-alpha: a more potent angiogenic mediator than epidermal growth factor. Science 1986, 232:1250-1253.
30. Ando N., Hirahara F., Fukushima J., Kawamoto S., Okuda K., Funabashi T., et al. Differential gene expression of TGF-beta isoforms and TGF-beta receptors during the first trimester of pregnancy and at the human maternal-fetal interface. Am J Reprod Immunol 1998, 40:48-56.
31. Lyall F., Simpson H., Bulmer J.N., Barber A., Robson S.C. Transforming growth factor-beta expression in human placenta and placental bed in third trimester normal pregnancy, preeclampsia, and fetal growth restriction. Am J Pathol 2001, 5:1827-1838.
32. Ogasawara M.S., Aoki K., Aoyama T., Katano K., Iinuma Y., Ozaki Y., et al. Elevation of transforming growth factor-beta1 is associated with recurrent miscarriage. J Clin Immunol 2000, 20:453-457.
33. Huber A., Hefler L., Tempfer C., Zeisler H., Lebrecht A., Husslein P. Transforming growth factor-beta 1 serum levels in pregnancy and pre-eclampsia. Acta Obstet Gynecol Scand 2002, 81:168-171.
34. Benian A., Madazli R., Aksu F., Uzun H., Aydin S. Plasma and placental levels of interleukin-10, transforming growth factor-beta1, and epithelial-cadherin in preeclampsia. Obstet Gynecol 2002, 100:327-331.
35. Hennessy A., Orange S., Willis N., Painter D.M., Child A., Horvath J.S. Transforming growth factor-beta1 does not relate to hypertension in pre-eclampsia. Clin Exp Pharmacol Physiol 2002, 29:968-971.
36. Lim J.H., Kim S.Y., Park S.Y., Lee M.H., Yang J.H., Kim M.Y., et al. Soluble endoglin and transforming growth factor-beta1 in women who subsequently developed preeclampsia. Prenat Diagn 2009, 29:471-476.
37. Todros T., Marzioni D., Lorenzi T., Piccoli E., Capparuccia L., Perugini V., et al. Evidence for a role of TGF-beta1 in the expression and regulation of alpha-SMA in fetal growth restricted placentae. Placenta 2007, 28:1123-1132.
38. Hahn-Zoric M., Hagberg H., Kjellmer I., Ellis J., Wennergren M., Hanson L.A. Aberrations in placental cytokine mRNA related to intrauterine growth retardation. Pediatr Res 2002, 51:201-206.
39. Ostlund E., Tally M., Fried G. Transforming growth factor-beta1 in fetal serum correlates with insulin-like growth factor-I and fetal growth. Obstet Gynecol 2002, 100:567-573.
40. Cucina A., Sterpetti A.V., Borrelli V., Pagliei S., Cavallaro A., D'Angelo L.S. Shear stress induces transforming growth factor-beta 1 release by arterial endothelial cells. Surgery 1998, 123:212-217.
41. Baskurt O.K., Meiselman H.J. Blood rheology and hemodynamics. Semin Thromb Hemost 2003, 29:435-450.
42. Maciorkowska E., Marcinkiewicz S., Kaczmarski M., Kemona A. Inflammatory changes of the gastric mucosa and serum concentration of chosen growth factors in children. Adv Med Sci 2010, 55:59-66.
43. Bannerman D.D., Paape M.J., Chockalingam A. Staphylococcus aureus intramammary infection elicits increased production of transforming growth factor-alpha, beta1, and beta2. Vet Immunol Immunopathol 2006, 112:309-315.
44. Surendar J., Aravindhan V., Rao M.M., Ganesan A., Mohan V. Decreased serum interleukin-17 and increased transforming growth factor-β levels in subjects with metabolic syndrome (Chennai Urban Rural Epidemiology Study-95). Metabolism 2011, 60:586-590.
45. Yener S., Demir T., Akinci B., Bayraktar F., Kebapcilar L., Ozcan M.A., et al. Transforming growth factor-beta 1 levels in women with prior history of gestational diabetes mellitus. Diabetes Res Clin Pract 2007, 76:193-198.
46. Bry K., Hallman M. Transforming growth factor-beta opposes the stimulatory effects of interleukin-1 and tumor necrosis factor on amnion cell prostaglandin E2 production: implication for preterm labor. Am J Obstet Gynecol 1992, 167:222-226.
47. Winkler M., Rath W. The role of cytokines in the induction of labor, cervical ripening and rupture of the fetal membranes. Z Geburtsh Neonatol 1996, 200(Suppl 1):1-12.
48. Pasetto N., Piccione E., Zicari A., Fontana L., De Carolis C., Perricone R., et al. Short report: cytokine production by human fetal membranes and uterine decidua at term gestation in relation to labour. Placenta 1993, 14:361-364.
49. Zicari A., Ticconi C., Realacci M., Cela O., Santangelo C., Pietropolli A., et al. Hormonal regulation of cytokine release by human fetal membranes at term gestation: effects of oxytokin, hydrocortisone and progesterone on tumour necrosis factor-alpha and transforming growth factor-beta1 output. J Reprod Immunol 2002, 56:123-136.